Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)
|
June 27, 2022
Real-World Experience with Intracapsular Administration of Dexamethasone Intraocular Suspension 9% for Control of Postoperative Inflammation
Cathleen McCabe, Priya Desai, Lisa Nijm, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
December 5, 2022
The REVIVE Study: Long Term Outcomes of a Novel Non-Diffractive Extended Vision IOL versus Monofocal Control IOL
Brian M Shafer, Cathleen McCabe, Harvey Reiser, et al.
Journal of Cataract and Refractive Surgery
|
January 27, 2022
A mysterious myopic surprise
Nicole R Fram, Sahar Bedrood, Georges M Durr, et al.
Journal of Cataract and Refractive Surgery
|
May 26, 2022
Clinical outcomes in a U.S. registration study of a new EDOF intraocular lens with a nondiffractive design
Cathleen McCabe, John Berdahl, Harvey Reiser, et al.
Ophthalmology
|
February 26, 2022
Long-term Outcomes from the HORIZON Randomized Trial for a Schlemm's Canal Microstent in Combination Cataract and Glaucoma Surgery
Iqbal Ike K Ahmed, Ticiana De Francesco, Douglas Rhee, et al.
Ophthalmology and Therapy
|
March 18, 2026
Postoperative Inflammation and Pain Management with Intracanalicular Dexamethasone Insert: Real-World Applications
Eric D Donnenfeld, Jordan Graff, Cathleen McCabe, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
June 10, 2022
First Real-World, Multicenter, Post-Marketing, Retrospective Study of Dexamethasone Intraocular Suspension for Inflammation After Cataract Surgery
Jason Bacharach, Cathleen McCabe, Mitchell Jackson, et al.
Journal of Cataract and Refractive Surgery
|
July 22, 2019
Results from the United States cohort of the HORIZON trial of a Schlemm canal microstent to reduce intraocular pressure in primary open-angle glaucoma
Jason Jones, Douglas D Koch, Steven Vold, et al.
JAMA Ophthalmology
|
March 3, 2022
Safety and Efficacy of AGN-190584 in Individuals With Presbyopia: The GEMINI 1 Phase 3 Randomized Clinical Trial
George O Waring, Francis W Price, David Wirta, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Clinical Ophthalmology (Auckland, N.Z.)
|
June 27, 2022
Real-World Experience with Intracapsular Administration of Dexamethasone Intraocular Suspension 9% for Control of Postoperative Inflammation
Cathleen McCabe, Priya Desai, Lisa Nijm, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
December 5, 2022
The REVIVE Study: Long Term Outcomes of a Novel Non-Diffractive Extended Vision IOL versus Monofocal Control IOL
Brian M Shafer, Cathleen McCabe, Harvey Reiser, et al.
Journal of Cataract and Refractive Surgery
|
January 27, 2022
A mysterious myopic surprise
Nicole R Fram, Sahar Bedrood, Georges M Durr, et al.
Journal of Cataract and Refractive Surgery
|
May 26, 2022
Clinical outcomes in a U.S. registration study of a new EDOF intraocular lens with a nondiffractive design
Cathleen McCabe, John Berdahl, Harvey Reiser, et al.
Ophthalmology
|
February 26, 2022
Long-term Outcomes from the HORIZON Randomized Trial for a Schlemm's Canal Microstent in Combination Cataract and Glaucoma Surgery
Iqbal Ike K Ahmed, Ticiana De Francesco, Douglas Rhee, et al.
Ophthalmology and Therapy
|
March 18, 2026
Postoperative Inflammation and Pain Management with Intracanalicular Dexamethasone Insert: Real-World Applications
Eric D Donnenfeld, Jordan Graff, Cathleen McCabe, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
June 10, 2022
First Real-World, Multicenter, Post-Marketing, Retrospective Study of Dexamethasone Intraocular Suspension for Inflammation After Cataract Surgery
Jason Bacharach, Cathleen McCabe, Mitchell Jackson, et al.
Journal of Cataract and Refractive Surgery
|
July 22, 2019
Results from the United States cohort of the HORIZON trial of a Schlemm canal microstent to reduce intraocular pressure in primary open-angle glaucoma
Jason Jones, Douglas D Koch, Steven Vold, et al.
JAMA Ophthalmology
|
March 3, 2022
Safety and Efficacy of AGN-190584 in Individuals With Presbyopia: The GEMINI 1 Phase 3 Randomized Clinical Trial
George O Waring, Francis W Price, David Wirta, et al.
Page
of 1